Enabling Awesome

Your partner in innovation

Enabling Awesome.

The journey from discovery to medical breakthrough demands imagination, speed, and focus. At Mission BioCapital, we provide early-stage capital to the next generation of awesome life science entrepreneurs and the platform where they can realize their visions. This approach has revolutionized the way life science start-ups progress from idea to key data through a model that champions collaboration at the center of everything we do.

Our team has a deep-rooted commitment to empowering exceptional life science entrepreneurs from all walks of life.

From your first experiment in our shared lab space through to the clinic, we want to be your partner in accelerating development of scientific solutions – faster, focused and more efficiently – to individuals and communities in most need.

We’re there, from idea to exit.

We are scientists, investors, founders, and serial entrepreneurs. Our team has a long history together, investing in, launching, and building dozens of early-stage life science companies.

Making Transformational Investments.

Founded in 2009, we are now investing out of our fifth fund. Since our inception, we have invested in early-stage life science companies following the same core principles:

News from Our Network

Follow us on twitter @MissionBioCap

Tune Therapeutics launches with $40M in funding, aims to fine-tune activity of genes in cells https://www.geekwire.com/2021/tune-therapeutics-launches-with-40m-in-funding-aims-to-fine-tune-activity-of-genes-in-cells/ via @GeekWire

LabCentral's own Celina Chang and Johannes Fruehauf weigh in on the importance of accessible RAPID testing in the latest from @BostonGlobe

Check it out here:

https://www.bostonglobe.com/2021/12/02/nation/how-fight-covid-again-again-rapid-tests/

Did you hear? Last week LabCentral announced the appointment of Gretchen Cook-Anderson to the role of executive director of @IgniteLC. With 25+ years of diversity leadership exp., Cook-Anderson will foster Ignite’s goal of expanding DEIB in biotech. https://labcentral.site/gret